OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
MEDA60

Medi Assist Healthcare Services Ltd

Managed HealthcareVerified

Medi Assist Healthcare Services Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.38, indicating a relatively low reliance on debt financing. The company's liquidity position is moderate, with a current ratio of 1.49, suggesting it can cover its short-term obligations but with limited excess capacity. Free cash flow of INR 734.55 million and operating cash flow of INR 1.38 billion support operational flexibility, though net cash is negative after subtracting total debt. Profitability metrics show a return on equity (ROE) of 16.78% and a return on assets (ROA) of 7.85%, both of which are strong indicators of efficient capital use and asset management. These figures are well above the typical benchmarks for the Managed Healthcare industry, suggesting Medi Assist is outperforming its peers in generating returns for shareholders and utilizing its asset base effectively. The company's revenue is distributed across three key segments: Retail, Group, and Government. While the exact revenue contribution from each segment is not disclosed, the presence of these segments indicates a diversified revenue base. The Government Segment likely provides a stable revenue stream, while the Retail and Group Segments may offer growth potential through expanding health insurance coverage and corporate wellness programs. Looking ahead, Medi Assist Healthcare Services Ltd is projected to maintain a steady growth trajectory. The company's operating income of INR 1.00 billion and net income of INR 908.79 million suggest a solid foundation for future expansion. Analysts have provided a mean price target of INR 583.33, with a median of INR 600.00, indicating a generally positive outlook on the company's future performance. Risk factors for Medi Assist include moderate liquidity risk, as highlighted by the negative net cash position after accounting for total debt. The company's dilution risk is assessed as low, with no significant dilution potential in the near term. However, the company's reliance on a few key segments and the potential for regulatory changes in the healthcare sector could pose challenges. Recent events and filings indicate a stable business environment for Medi Assist. The company's recent financial performance and strong analyst recommendations suggest confidence in its business model and future prospects. The absence of significant negative events in the recent filings supports the view that the company is well-positioned to continue its growth trajectory.

30-day price · MEDA+67.70 (+21.3%)
Low$302.95High$406.45Close$384.80As of17 May, 00:00 UTC
Profile
CompanyMedi Assist Healthcare Services Ltd
TickerMEDA.NS
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryManaged Healthcare
AI analysis

Business. Medi Assist Healthcare Services Ltd provides health benefits administration services, technology platforms, and other offerings to the health insurance ecosystem, acting as a facilitator between insurance companies, policyholders, healthcare providers, and government beneficiaries.

Classification. Medi Assist Healthcare Services Ltd is classified under the Healthcare sector, specifically in the Managed Healthcare industry, with a confidence level of 0.92.

Medi Assist Healthcare Services Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.38, indicating a relatively low reliance on debt financing. The company's liquidity position is moderate, with a current ratio of 1.49, suggesting it can cover its short-term obligations but with limited excess capacity. Free cash flow of INR 734.55 million and operating cash flow of INR 1.38 billion support operational flexibility, though net cash is negative after subtracting total debt. Profitability metrics show a return on equity (ROE) of 16.78% and a return on assets (ROA) of 7.85%, both of which are strong indicators of efficient capital use and asset management. These figures are well above the typical benchmarks for the Managed Healthcare industry, suggesting Medi Assist is outperforming its peers in generating returns for shareholders and utilizing its asset base effectively. The company's revenue is distributed across three key segments: Retail, Group, and Government. While the exact revenue contribution from each segment is not disclosed, the presence of these segments indicates a diversified revenue base. The Government Segment likely provides a stable revenue stream, while the Retail and Group Segments may offer growth potential through expanding health insurance coverage and corporate wellness programs. Looking ahead, Medi Assist Healthcare Services Ltd is projected to maintain a steady growth trajectory. The company's operating income of INR 1.00 billion and net income of INR 908.79 million suggest a solid foundation for future expansion. Analysts have provided a mean price target of INR 583.33, with a median of INR 600.00, indicating a generally positive outlook on the company's future performance. Risk factors for Medi Assist include moderate liquidity risk, as highlighted by the negative net cash position after accounting for total debt. The company's dilution risk is assessed as low, with no significant dilution potential in the near term. However, the company's reliance on a few key segments and the potential for regulatory changes in the healthcare sector could pose challenges. Recent events and filings indicate a stable business environment for Medi Assist. The company's recent financial performance and strong analyst recommendations suggest confidence in its business model and future prospects. The absence of significant negative events in the recent filings supports the view that the company is well-positioned to continue its growth trajectory.
Key takeaways
  • Medi Assist Healthcare Services Ltd has a strong return on equity (16.78%) and return on assets (7.85%), indicating efficient capital and asset utilization.
  • The company maintains a conservative debt-to-equity ratio of 0.38, suggesting a relatively low financial risk profile.
  • Analysts have provided a generally positive outlook, with a mean price target of INR 583.33 and a median of INR 600.00.
  • The company's liquidity position is moderate, with a current ratio of 1.49, indicating it can cover its short-term obligations but with limited excess capacity.
  • Medi Assist's business is diversified across three key segments: Retail, Group, and Government, which may provide a stable and growing revenue base.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$7.23B
Gross profit$7.19B
Operating income$1.00B
Net income$908.8M
R&D
SG&A
D&A
SBC
Operating cash flow$1.38B
CapEx-$457.9M
Free cash flow$734.5M
Total assets$11.58B
Total liabilities$6.17B
Total equity$5.41B
Cash & equivalents$548.8M
Long-term debt$2.04B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$5.41B
Net cash-$1.49B
Current ratio1.5
Debt/Equity0.4
ROA7.8%
ROE16.8%
Cash conversion1.5%
CapEx/Revenue-6.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 5 companies
MetricMEDAActivity
Op margin13.8%13.3% medp25 5.9% · p75 13.5%top quartile
Net margin12.6%8.6% medp25 2.7% · p75 12.7%above median
Gross margin99.4%64.0% medp25 60.1% · p75 65.6%top quartile
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-6.3%3.0% medp25 2.7% · p75 4.5%bottom quartile
Debt / equity38.0%69.3% medp25 63.4% · p75 74.5%bottom quartile
Observations
IR observations
Mean price target583.33 INR
Median price target600.00 INR
High price target610.00 INR
Low price target540.00 INR
Mean recommendation1.67 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count2.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate7.45 INR
Last actual EPS12.85 INR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 16:28 UTC#120849a0
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 16:30 UTCJob: b4c71766